骨肉瘤的基因免疫治疗:从溶瘤载体到工程化免疫细胞
Gene-based immunotherapy in osteosarcoma: from oncolytic vectors to engineered immune cells.
77.2分
★★★★☆
站内排序·非疗效
ALL SOURCES
Gene-based immunotherapy in osteosarcoma: from oncolytic vectors to engineered immune cells.
Reprogramming adoptive cell therapy for osteosarcoma: engineering, vaccination, and tumor microenvironment remodeling.
A Bibliometric and Knowledge-Map Analysis of CAR-T Cells From 2009 to 2021.
作为一种具有巨大潜力和临床应用前景的抗肿瘤疗法,CAR-T 细胞疗法仍处于快速发展阶段。CAR-T 细胞相关领域在未来仍将是研究热点。
Comprehensive analysis of tumor necrosis factor-α-inducible protein 8-like 2 (TIPE2): A potential novel pan-cancer immune checkpoint.
共 4 条
MEMBER ACCOUNT
登录成功会直接打开下一页。